amantadine has been researched along with adamantane in 74 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 38 (51.35) | 18.7374 |
1990's | 7 (9.46) | 18.2507 |
2000's | 9 (12.16) | 29.6817 |
2010's | 14 (18.92) | 24.3611 |
2020's | 6 (8.11) | 2.80 |
Authors | Studies |
---|---|
Stone, TW | 1 |
Bauer, DJ; Tisdale, M | 1 |
Galasso, GJ; LaMontagne, JR | 1 |
Hassett, CM; Mansfield, JI; Price, PJ | 1 |
Dette-Wildenhahn, G; Fellehner, H; Wesemann, W | 1 |
Kramer, MJ; Levitan, P; Tilley, JW | 1 |
Fanta, D | 1 |
Oxford, JS | 1 |
Bigalke, H; Lampe, H | 1 |
Bormann, J; Hübers, M; Kornhuber, J; Riederer, P; Rusche, K | 1 |
Betts, RF | 1 |
Belshe, RB; Burk, B; Cerruti, RL; Newman, F; Sim, IS | 1 |
Donath, E; Donath, J; el-Karadagi, S; Glaser, R; Herrmann, A; Kharitonenkov, IG; Lentzsch, P; Tverdislov, VA | 1 |
Coakley, WT; Donath, E; Egger, M; Groth, T; Herrmann, A; Taeger, M | 1 |
Donath, E; Egger, M; Glaser, R; Ziemer, S | 1 |
Blasecki, JW; Gaylord, JC; Hoffman, HE; Shalaby, LM; Whitney, CC | 1 |
Hayden, FG; Tominack, RL | 1 |
Spector, R | 1 |
Garrino, MG; Henquin, JC | 1 |
Jannasch, R | 1 |
Bean, WJ; Kawaoka, Y; Webster, RG | 1 |
Hayden, FG; Hoffman, HE; Minocha, A; Spyker, DA | 1 |
Bean, WJ; Beard, CW; Brugh, M; Kawaoka, Y; Webster, RG | 1 |
Döhner, L; Mentel, R; Panzig, B; Seidel, W | 1 |
Gibb, W; Jeffery, J | 1 |
Adamczyk, B; Feldblum, R; Heider, H; Indulen, MK; Presber, HW; Schroeder, C | 1 |
Alonso, ML; Minguez, F; Moya, P; Ronda, E | 1 |
Yaar, I | 1 |
Bucher, DJ; El Karadaghi, S; Kharitonenkov, IG; Tverdislov, VA; Zakomirdin, JA | 1 |
Sebastiani, A | 1 |
Garcia Gil, M; Sanchez Crespo, M | 1 |
Balda, BR; Przybilla, B; Wagner-Grösser, G | 1 |
Hayden, FG; Hoffman, HE; Spyker, DA | 1 |
Bryson, YJ; Dreisbach, M; Millet, VM | 1 |
Dolin, R; Linton, PN; Madore, HP; Maynard, R; Reichman, RC; Webber-Jones, J | 1 |
Burlington, DB; Meiklejohn, G; Mostow, SR | 2 |
Cate, TR; Couch, RB; Goswick, CB; Quarles, JM | 1 |
Adams, KF; Giordani, B; Gwaltney, JM; Hayden, FG; Van de Castle, RL | 1 |
Kornhuber, J; Riederer, P; Schoppmeyer, K; Weller, M | 1 |
Evans, SG; Havlik, I | 1 |
Koshelev, S; Sobolevsky, A | 1 |
Avdiunina, NI; Barchukov, VG; Ivanova, IA; Klimova, NV; Kovalev, GI; Morozov, IS; Piatin, BM; Sergeeva, SA | 1 |
Alymova, IV; Bogdan, OP; Bukrinskaya, AG; Burstein, ME; Jdanov, VV; Khakhulina, TV; Manukchina, EE; Serbin, AV; Sharova, NK; Stotskaya, LL | 1 |
Sobolevsky, AI; Yelshansky, MV | 1 |
Vamvakidès, A | 1 |
Borek-Dohalská, L; Frei, E; Hodek, P; Mráz, J; Stiborová, M | 1 |
Bol'shakov, KV; Buldakova, SL; Gmiro, VE; Magazanik, LG; Samoilova, MV; Tikhonov, DB | 1 |
Gebicka, L; Kochman, A; Metodiewa, D; Skolimowski, J | 1 |
Lu, Q | 1 |
Kelly, JM; Kolocouris, N; Papanastasiou, I; Prathalingam, SR; Tsotinis, A | 1 |
De Clercq, E; Hay, AJ; Kolocouris, A; López-Querol, M; Martin, SR; Neyts, J; Padalko, E; Spearpoint, P; Sureda, FX | 1 |
Arkin, IT; Astrahan, P | 1 |
Antipova, TA; Kovalev, GI; Logvinov, IO; Zimin, IA | 1 |
Arkin, IT; Astrahan, P; Krugliak, M; Leonov, H | 1 |
Ivanova, EA; Kapitsa, IG; Kokshenev, II; Nepoklonov, AV; Val'dman, EA; Voronina, TA | 1 |
Garibova, TL; Ivanova, EA; Kokshenev, II; Kotel'nikova, SO; Kraĭneva, VA; Nepoklonov, AV; Val'dman, EA; Voronina, TA | 1 |
Ivanova, EA; Kapitsa, IG; Nepoklonov, AV; Val'dman, EA; Voronina, TA | 1 |
Busath, DD; Cross, TA; Fedida, D; Johnson, FB; Kolocouris, A; Tietjen, I; Tzitzoglaki, C; Wright, AK; Zell, R | 1 |
Berg, JD; Ford, LT | 1 |
Antipova, TA; Logvinov, IO; Nepoklonov, AV; Valdman, EA | 1 |
DeGrado, WF; Hu, Y; Ma, C; Musharrafieh, R; Smee, DF; Wang, J; Zhang, J | 1 |
Boeckler, FM; Breitinger, HG; Breitinger, U; Ma, C; Mandour, YM; Wang, J; Zlotos, DP | 1 |
Amentisch, H; Chountoulesi, M; Demetzos, C; Kiriakidi, S; Kolocouris, A; Kolokouris, D; Konstantinidi, A; Mali, G; Mavromoustakos, T; Naziris, N; Ntountaniotis, D; Sartori, B | 1 |
Kolik, LG; Konstantinopolsky, MA | 1 |
DeGrado, WF; Liu, L; Polizzi, N; Thomaston, JL; Wang, J; Wu, Y | 1 |
Adotevi, N; Dabrowska, N; Joshi, S; Kapur, J; Lewczuk, E; Shan, S; Sun, H; Williamson, J | 1 |
Grieb, P; Rejdak, K | 1 |
Brenner, SR | 1 |
Barbier, J; Cintrat, JC; Gillet, D; Huang, X; Jiang, C; Li, J; Liu, H; Sheng, R; Su, W; Sun, J; Wu, J; Wu, M; Wu, Y; Zhao, G | 1 |
Barchanska, H; Kostina-Bednarz, M; Płonka, J | 1 |
Aksinenko, AY; Bachurin, SO; Dubrovskaya, ES; Epishina, TA; Fisenko, VP; Goreva, TV; Grigoriev, VV; Lapshina, MA; Makhaeva, GF; Maleev, GV; Shevtsova, EF; Steinberg, DA; Ustyugov, AA; Veselov, IM; Vinogradova, DV; Zamoyski, VL | 1 |
7 review(s) available for amantadine and adamantane
Article | Year |
---|---|
Specific inhibitors of influenza virus replication as potential chemoprophylactic agents.
Topics: Adamantane; Amantadine; Animals; Antiviral Agents; DNA-Directed RNA Polymerases; Drug Resistance, Microbial; Humans; Influenza, Human; Models, Molecular; Orthomyxoviridae; Ribavirin; Virus Replication | 1975 |
Amantadine and rimantadine for the prevention of influenza A.
Topics: Adamantane; Adult; Age Factors; Aged; Amantadine; Child; Humans; Influenza A virus; Influenza, Human; Rimantadine; Seasons; United States | 1989 |
Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections.
Topics: Adamantane; Adult; Aged; Amantadine; Humans; Influenza A virus; Influenza, Human; Rimantadine | 1987 |
Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.
Topics: Adamantane; Amantadine; Animals; Behavior, Animal; Dopamine; Electrophysiology; Hallucinogens; Humans; Memantine; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Substance-Related Disorders | 1994 |
[Adamantane derivatives enhancing body's resistance to emergencies].
Topics: Adamantane; Amantadine; Animals; General Adaptation Syndrome; Humans; Mice; Psychotropic Drugs; Rats; Stress, Psychological | 1999 |
Antiviral therapy and prophylaxis for influenza in children.
Topics: Adamantane; Amantadine; Antiviral Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Influenza, Human; Male; Oseltamivir; Primary Prevention; Prospective Studies; Randomized Controlled Trials as Topic; Rimantadine; Risk Assessment; Severity of Illness Index; Treatment Outcome; Zanamivir | 2007 |
Resistance characteristics of influenza to amino-adamantyls.
Topics: Adamantane; Amantadine; Amino Acid Sequence; Drug Resistance, Viral; Genes, Viral; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A virus; Influenza, Human; Ion Channels; Models, Molecular; Molecular Sequence Data; Mutation; Protein Stability; Protein Structure, Tertiary; Rimantadine; Sequence Homology, Amino Acid; Viral Matrix Proteins | 2011 |
7 trial(s) available for amantadine and adamantane
Article | Year |
---|---|
From the National Institutes of Health. Report of a workshop on clinical studies of the efficacy of amantadine and rimantadine against influenza vireus.
Topics: Adamantane; Amantadine; Bridged-Ring Compounds; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Humans; In Vitro Techniques; Influenza, Human; Michigan; National Institutes of Health (U.S.); Orthomyxoviridae; Placebos; United States | 1978 |
[Treatment of herpes simplex using tromantadine hydrochloride].
Topics: Adamantane; Amantadine; Clinical Trials as Topic; Drug Evaluation; Drug Tolerance; Herpes Simplex; Humans | 1976 |
Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults.
Topics: Adamantane; Adult; Aged; Amantadine; Female; Humans; Kinetics; Male; Metabolic Clearance Rate; Mucus; Nasal Mucosa; Rimantadine | 1985 |
Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics.
Topics: Adamantane; Adult; Amantadine; Central Nervous System; Digestive System; Humans; Kinetics; Middle Aged; Rimantadine; Sleep | 1983 |
Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramine.
Topics: Adamantane; Adolescent; Adult; Amantadine; Central Nervous System; Chlorpheniramine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Rimantadine | 1982 |
A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection.
Topics: Adamantane; Adolescent; Adult; Amantadine; Clinical Trials as Topic; Humans; Infant, Newborn; Influenza A virus; Influenza, Human; Middle Aged; Patient Compliance; Random Allocation; Rimantadine | 1982 |
Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults.
Topics: Adamantane; Adult; Amantadine; Central Nervous System Diseases; Gastrointestinal Diseases; Humans; Motor Skills; Rimantadine; Sleep Wake Disorders; Time Factors | 1981 |
60 other study(ies) available for amantadine and adamantane
Article | Year |
---|---|
Comparison of neuronal responses to amantadine and rimantadine: use of alpha-flupenthixol.
Topics: Adamantane; Amantadine; Animals; Bridged-Ring Compounds; Cerebral Cortex; Dopamine Antagonists; Flupenthixol; Male; Neurons; Phentolamine; Propranolol; Rats; Synaptic Transmission; Thioxanthenes | 1978 |
The relative potencies of anti-influenza compounds.
Topics: Adamantane; Amantadine; Amines; Animals; Antiviral Agents; Cells, Cultured; Cycloparaffins; Influenza A virus; Mice; Microbial Sensitivity Tests; Orthomyxoviridae Infections; Ribavirin | 1977 |
Rimantadine but not amantadine protects Fischer rat embryo cells from transformation induced by 3-methylcholanthrene or benzo(a)pyrene.
Topics: Adamantane; Amantadine; Animals; Benzopyrenes; Bridged-Ring Compounds; Cell Line; Cell Transformation, Neoplastic; Methylcholanthrene; Rats | 1979 |
In vitro studies on the possible effects of 1-aminoadamantanes on the serotonergic system in M. Parkinson.
Topics: Adamantane; Amantadine; Animals; Biological Transport; Bridged-Ring Compounds; Electric Stimulation; Kinetics; Male; Parkinson Disease; Rats; Serotonin; Synapses; Synaptic Membranes; Synaptic Vesicles; Synaptosomes | 1979 |
Adamantylthiourea derivatives as antiviral agents.
Topics: Adamantane; Amantadine; Animals; Antiviral Agents; Lethal Dose 50; Mice; Orthomyxoviridae Infections; Thiourea | 1979 |
Modulation of glycine-activated membrane current by adamantane derivatives.
Topics: Adamantane; Amantadine; Animals; Cell Membrane; Cells, Cultured; Chloride Channels; Fetus; gamma-Aminobutyric Acid; Glycine; Ion Channels; Membrane Potentials; Membrane Proteins; Mice; Neurons; Spinal Cord | 1991 |
Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.
Topics: Adamantane; Amantadine; Binding Sites; Brain; Dizocilpine Maleate; Humans; Ion Channel Gating; Ion Channels; Kinetics; Memantine; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship; Tritium | 1991 |
Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance.
Topics: Adamantane; Amantadine; Animals; Antigens, Viral; Cell Line; Cytopathogenic Effect, Viral; Dogs; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Humans; Influenza A virus; Influenza, Human; Rimantadine; Viral Plaque Assay | 1989 |
Interaction of the antivirus agents remantadine and amantadine with lipid membranes and the influence on the curvature of human red cells.
Topics: Adamantane; Amantadine; Elasticity; Electron Spin Resonance Spectroscopy; Erythrocyte Deformability; Humans; Intracellular Membranes; Membrane Lipids; Rimantadine; Time Factors | 1986 |
The influence of the antiviral drugs amantadine and rimantadine on erythrocyte and platelet membranes and its comparison with that of tetracaine.
Topics: Adamantane; Amantadine; Antiviral Agents; Blood Platelets; Cell Fractionation; Electron Spin Resonance Spectroscopy; Erythrocyte Membrane; Hemagglutination, Viral; Humans; Osmotic Fragility; Platelet Aggregation; Rimantadine; Tetracaine | 1987 |
Electrorotation--a new method for investigating membrane events during thrombocyte activation. Influence of drugs and osmotic pressure.
Topics: Adamantane; Amantadine; Blood Platelets; Calcimycin; Cell Membrane; Chlorpromazine; Electrochemistry; Humans; Light; Mathematics; Osmotic Pressure; Platelet Aggregation; Rimantadine; Scattering, Radiation; Thrombin | 1986 |
Pharmacokinetics and metabolism of rimantadine hydrochloride in mice and dogs.
Topics: Adamantane; Administration, Oral; Amantadine; Animals; Biological Availability; Dogs; Dose-Response Relationship, Drug; Feces; Female; Gas Chromatography-Mass Spectrometry; Lung; Metabolic Clearance Rate; Mice; Orthomyxoviridae Infections; Rimantadine | 1988 |
Transport of amantadine and rimantadine through the blood-brain barrier.
Topics: Adamantane; Amantadine; Animals; Biological Transport; Blood-Brain Barrier; Perfusion; Rats; Rats, Inbred Strains; Rimantadine | 1988 |
Adamantane derivatives: a new class of insulin secretagogues.
Topics: Adamantane; Amantadine; Animals; Calcium; Female; Glucose; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Membrane Potentials; Mice | 1987 |
[Capillary isotachophoresis--a new method in drug analysis. 3. Analytic capillary isotachophoresis for the determination of amantadine and rimantadine].
Topics: Adamantane; Amantadine; Capsules; Electrophoresis; Rimantadine; Spectrophotometry, Ultraviolet; Tablets | 1986 |
Vaccination as a strategy to reduce the emergence of amantadine- and rimantadine-resistant strains of A/Chick/Pennsylvania/83 (H5N2) influenza virus.
Topics: Adamantane; Amantadine; Animals; Drug Resistance, Microbial; Influenza A virus; Influenza A Virus, H5N2 Subtype; Influenza Vaccines; Orthomyxoviridae Infections; Poultry; Poultry Diseases; Rimantadine; Vaccination | 1986 |
Current status of amantadine and rimantadine as anti-influenza-A agents: memorandum from a WHO meeting.
Topics: Adamantane; Amantadine; Humans; Influenza A virus; Influenza, Human; Rimantadine | 1985 |
Chemotherapy and vaccination: a possible strategy for the control of highly virulent influenza virus.
Topics: Adamantane; Amantadine; Animals; Chickens; Drug Resistance, Microbial; Influenza A virus; Influenza in Birds; Rimantadine; Vaccination; Viral Vaccines | 1985 |
[Action of antiviral substances on influenza viruses through the inhibition of neuraminidase production].
Topics: Adamantane; Amantadine; Animals; Chick Embryo; Culture Techniques; Fibroblasts; Influenza A virus; Neuraminidase; Rimantadine | 1985 |
Reduction of the non-steroid adamantanone by crystalline preparations of cortisone reductase.
Topics: Adamantane; Amantadine; Bridged-Ring Compounds; Catalysis; Cortisone; Cycloparaffins; Hydroxysteroid Dehydrogenases; Ketones; Ketosteroids; Kinetics; NAD; Oxidation-Reduction; Pregnanes; Spectrophotometry; Structure-Activity Relationship | 1972 |
Occurrence of amantadine- and rimantadine-resistant influenza A virus strains during the 1980 epidemic.
Topics: Adamantane; Amantadine; Drug Resistance, Microbial; Humans; Influenza A virus; Mutation; Rimantadine | 1981 |
'In vivo' variations in serum interferon levels produced by antiviral compounds.
Topics: Adamantane; Amantadine; Animals; Chickens; Glucosamine; Interferons; Male; Mice; Mice, Inbred BALB C | 1983 |
The effects of amantadine, rimantadine and levodopa on the frequency of fibrillation potentials in denervated muscle.
Topics: Acetylcholine; Adamantane; Amantadine; Animals; Electromyography; Levodopa; Muscle Contraction; Muscle Denervation; Rats; Receptors, Cholinergic; Rimantadine | 1984 |
Interaction of influenza virus proteins with planar bilayer lipid membranes. II. Effects of rimantadine and amantadine.
Topics: Adamantane; Amantadine; Dose-Response Relationship, Drug; Kinetics; Lipid Bilayers; Membrane Potentials; Phosphatidylcholines; Phospholipids; Rimantadine; Viral Matrix Proteins; Viral Proteins | 1984 |
[Amantadine and riamantadine in the treatment of influenza].
Topics: Adamantane; Amantadine; Humans; Influenza, Human; Rimantadine | 1983 |
Dansylcadaverine and rimantadine inhibition of phagocytosis, PAF-acether release, and phosphatidylcholine synthesis in human polymorphonuclear leukocytes.
Topics: Adamantane; Amantadine; Antineoplastic Agents; Cadaverine; Diamines; Humans; Neutrophils; Phagocytosis; Phosphatidylcholines; Platelet Activating Factor; Rimantadine | 1983 |
[Contact-allergic cross-reactions of tromantadine and amantadine].
Topics: Adamantane; Adult; Amantadine; Cross Reactions; Dermatitis, Contact; Drug Hypersensitivity; Female; Humans; Male; Middle Aged | 1983 |
Anti-influenza A virus activity of amantadine hydrochloride and rimantadine hydrochloride in ferret tracheal ciliated epithelium.
Topics: Adamantane; Amantadine; Animals; Cilia; Cytopathogenic Effect, Viral; Epithelium; Ferrets; In Vitro Techniques; Influenza A virus; Rimantadine; Time Factors; Trachea; Virus Cultivation | 1982 |
Toxicity of amantadine and rimantadine for the ciliated epithelium of ferret tracheal rings.
Topics: Adamantane; Amantadine; Animals; Cilia; Ferrets; In Vitro Techniques; Rimantadine; Trachea | 1981 |
Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza.
Topics: Adamantane; Adolescent; Adult; Age Factors; Amantadine; Antibodies, Viral; Double-Blind Method; Drug Evaluation; Female; Humans; Influenza A virus; Influenza, Human; Male; Rimantadine | 1981 |
Effect of pH on in vitro potency of amantadine against Plasmodium falciparum.
Topics: Adamantane; Amantadine; Ammonium Chloride; Animals; Antimalarials; Chloroquine; Culture Media; Dose-Response Relationship, Drug; Drug Resistance; Humans; Hydrogen-Ion Concentration; Mefloquine; Plasmodium falciparum; Quinine | 1996 |
Two blocking sites of amino-adamantane derivatives in open N-methyl-D-aspartate channels.
Topics: Adamantane; Amantadine; Animals; Binding Sites; Cell Membrane; Cell Separation; Hippocampus; In Vitro Techniques; Kinetics; Memantine; Membrane Potentials; Models, Chemical; Models, Molecular; Patch-Clamp Techniques; Pyramidal Cells; Rats; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship | 1998 |
Inhibition of HIV-1 replication by newly developed adamantane-containing polyanionic agents.
Topics: Adamantane; Anti-HIV Agents; Cell Line; Drug Design; HIV Core Protein p24; HIV-1; Humans; Immunoblotting; Jurkat Cells; Viral Proteins; Virus Replication | 1999 |
The trapping block of NMDA receptor channels in acutely isolated rat hippocampal neurones.
Topics: Adamantane; Amantadine; Animals; Antiparkinson Agents; Aspartic Acid; Cell Separation; Dopamine Agents; Dose-Response Relationship, Drug; Hippocampus; In Vitro Techniques; Ion Channels; Magnesium; Membrane Potentials; Neurons; Patch-Clamp Techniques; Perfusion; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2000 |
[Effect of amantadine or 3-cyclopentyl adamantanamine on the immobility of adult or aged mice, in the forced swim test].
Topics: Adamantane; Aging; Amantadine; Animals; Antiparkinson Agents; Brain; Imipramine; Male; Mice; Mice, Inbred BALB C; Restraint, Physical; Stress, Psychological; Swimming | 2000 |
New selective inhibitors of cytochromes P450 2B and their application to antimutagenesis of tamoxifen.
Topics: Adamantane; Amantadine; Animals; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 Enzyme Inhibitors; DNA Adducts; Endometrial Neoplasms; Enzyme Activation; Enzyme Inhibitors; Female; Humans; Inhibitory Concentration 50; Kinetics; Microsomes; Models, Chemical; Mutagens; Oxygen; Rabbits; Steroid Hydroxylases; Tamoxifen | 2002 |
Studies of the structure of glutamate receptor ion channels and the mechanisms of their blockade by organic cations.
Topics: Adamantane; Amantadine; Animals; Animals, Newborn; Brain; Cations; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; In Vitro Techniques; Ion Channels; Models, Biological; Models, Molecular; Neurons; Patch-Clamp Techniques; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2003 |
Synthesis and antioxidant activity evaluation of novel antiparkinsonian agents, aminoadamantane derivatives of nitroxyl free radical.
Topics: Adamantane; Amantadine; Animals; Antioxidants; Antiparkinson Agents; Brain; Dopamine; Female; Free Radicals; Immunohistochemistry; Molecular Structure; Nitrogen Oxides; Parkinsonian Disorders; Piperidines; Rats; Rats, Inbred BUF; Reactive Oxygen Species; Spectrophotometry; Tyrosine 3-Monooxygenase | 2003 |
[Treatment of influenza in children].
Topics: Adamantane; Amantadine; Antiviral Agents; Child; Guanidines; Humans; Influenza, Human; Pyrans; Rimantadine; Sialic Acids; Zanamivir | 2003 |
Design, synthesis, and trypanocidal activity of new aminoadamantane derivatives.
Topics: Adamantane; Amantadine; Animals; Parasitic Sensitivity Tests; Rimantadine; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei | 2008 |
Comparisons of the influenza virus A M2 channel binding affinities, anti-influenza virus potencies and NMDA antagonistic activities of 2-alkyl-2-aminoadamantanes and analogues.
Topics: Adamantane; Amantadine; Antiviral Agents; Influenza A virus; Molecular Structure; N-Methylaspartate; Structure-Activity Relationship; Viral Matrix Proteins | 2008 |
[A comparative study of hemantane and amantadine effects on dopamine transporter expression in brain of normal and MPTP-treated C57BL/6 mice].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; Amantadine; Animals; Antiparkinson Agents; Brain; Dopamine Plasma Membrane Transport Proteins; Drug Synergism; Male; Mice; Mice, Inbred C57BL; Parkinsonian Disorders | 2011 |
How do aminoadamantanes block the influenza M2 channel, and how does resistance develop?
Topics: Adamantane; Amantadine; Antiviral Agents; Binding Sites; Drug Resistance, Viral; Humans; Ion Channels; Mutation; Rimantadine; Static Electricity; Viral Matrix Proteins | 2011 |
[Comparative study of amantadine and hemantane effects on development of levodopa-induced dyskinesia in rat model of parkinsonian syndrome].
Topics: Adamantane; Amantadine; Animals; Behavior, Animal; Benserazide; Disease Models, Animal; Dyskinesia, Drug-Induced; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Rats; Substantia Nigra | 2011 |
[Comparative study of himantane and amantadine effects in experimental intracerebral posttraumatic hematoma].
Topics: Adamantane; Amantadine; Animals; Antiparkinson Agents; Cerebral Hemorrhage, Traumatic; Disease Models, Animal; Exploratory Behavior; Male; Memory; Muscle Tonus; Rats | 2012 |
[Study of hemantane effects in rats on a model of early (premotor) stage of Parkinson's disease].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; Amantadine; Animals; Antiparkinson Agents; Cognition; Drug Administration Schedule; Male; Neurotoxins; Parkinson Disease, Secondary; Rats; Time Factors | 2012 |
Aminoadamantanes with persistent in vitro efficacy against H1N1 (2009) influenza A.
Topics: Adamantane; Amantadine; Animals; Antiviral Agents; Dogs; Drug Resistance, Multiple, Viral; HEK293 Cells; Humans; Influenza A Virus, H1N1 Subtype; Ion Channels; Madin Darby Canine Kidney Cells; Mutation; Rimantadine; Viral Matrix Proteins | 2014 |
1-Adamantylamine a simple urine marker for screening for third generation adamantyl-type synthetic cannabinoids by ultra-performance liquid chromatography tandem mass spectrometry.
Topics: Adamantane; Adult; Amantadine; Cannabinoids; Chromatography, High Pressure Liquid; Female; Humans; Illicit Drugs; Indazoles; Indoles; Limit of Detection; Male; Substance Abuse Detection; Tandem Mass Spectrometry; United Kingdom | 2016 |
[COMPARISON OF CYTOPROTECTIVE EFFECTS OF HEMANTANE AND AMANTADINE UNDER CONDITIONS OF 6-HYDROXYDOPAMINE NEUROTOXIN ACTION ON CULTURED HUMAN NEUROBLASTOMA CELLS].
Topics: Adamantane; Amantadine; Cell Line, Tumor; Cytoprotection; Dose-Response Relationship, Drug; Humans; Models, Biological; Neuroblastoma; Parkinsonian Disorders | 2016 |
An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
Topics: Adamantane; Amantadine; Animals; Antiviral Agents; Dogs; Drug Resistance, Viral; Humans; Influenza A virus; Influenza, Human; Inhibitory Concentration 50; Madin Darby Canine Kidney Cells; Molecular Dynamics Simulation; Mutation; Orthomyxoviridae Infections; Spiro Compounds; Structure-Activity Relationship; Viral Matrix Proteins | 2017 |
Symmetric dimeric adamantanes for exploring the structure of two viroporins: influenza virus M2 and hepatitis C virus p7.
Topics: Adamantane; Amantadine; Antiviral Agents; Cells, Cultured; Drug Design; HEK293 Cells; Humans; Models, Molecular; Molecular Structure; Rimantadine; Viral Matrix Proteins; Viral Proteins | 2018 |
Comparative Perturbation Effects Exerted by the Influenza A M2 WT Protein Inhibitors Amantadine and the Spiro[pyrrolidine-2,2'-adamantane] Variant AK13 to Membrane Bilayers Studied Using Biophysical Experiments and Molecular Dynamics Simulations.
Topics: Adamantane; Amantadine; Binding Sites; Calorimetry, Differential Scanning; Dimyristoylphosphatidylcholine; Influenza A virus; Lipid Bilayers; Magnetic Resonance Spectroscopy; Molecular Dynamics Simulation; Nuclear Magnetic Resonance, Biomolecular; Scattering, Small Angle; Viral Matrix Proteins; X-Ray Diffraction | 2018 |
Comparative Assessment of the Effectiveness of Noncompetitive NMDA Receptor Antagonists Amantadine and Hemantane in Morphine Withdrawal Syndrome Model.
Topics: Adamantane; Amantadine; Animals; Gene Expression; Hyperalgesia; Injections, Intraperitoneal; Male; Morphine; Morphine Dependence; Motor Activity; Narcotic Antagonists; Rats; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome; Weight Loss | 2019 |
X-ray Crystal Structure of the Influenza A M2 Proton Channel S31N Mutant in Two Conformational States: An Open and Shut Case.
Topics: Adamantane; Amantadine; Asparagine; Binding Sites; Crystallography, X-Ray; Drug Resistance, Viral; Hydrogen Bonding; Hydrogen-Ion Concentration; Influenza A virus; Models, Molecular; Nuclear Magnetic Resonance, Biomolecular; Protein Conformation; Viral Matrix Proteins | 2019 |
α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor Plasticity Sustains Severe, Fatal Status Epilepticus.
Topics: Adamantane; Amantadine; Animals; Atropine; CA1 Region, Hippocampal; Dose-Response Relationship, Drug; Electric Stimulation; Female; Gene Knockdown Techniques; Hippocampus; Male; Mice; Mice, Knockout; Neuronal Plasticity; Receptors, AMPA; Status Epilepticus; Synaptic Transmission | 2020 |
Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment.
Topics: Adamantane; Adult; Aged; Aged, 80 and over; Amantadine; Asymptomatic Infections; Betacoronavirus; Cognitive Dysfunction; Coronavirus Infections; COVID-19; Dopamine Agents; Female; Humans; Male; Memantine; Middle Aged; Multiple Sclerosis; Pandemics; Parkinson Disease; Pneumonia, Viral; Protective Factors; SARS-CoV-2; Severity of Illness Index | 2020 |
The potential of memantine and related adamantanes such as amantadine, to reduce the neurotoxic effects of COVID-19, including ARDS and to reduce viral replication through lysosomal effects.
Topics: Adamantane; Amantadine; COVID-19; Humans; Lysosomes; Memantine; Respiratory Distress Syndrome; Respiratory Insufficiency; SARS-CoV-2; Virus Replication | 2020 |
Antiviral Effects of ABMA and DABMA against Influenza Virus In Vitro and In Vivo via Regulating the Endolysosomal Pathway and Autophagy.
Topics: Adamantane; Amantadine; Animals; Antiviral Agents; Autophagy; Endosomes; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Mice; Molecular Docking Simulation; p-Dimethylaminoazobenzene | 2022 |
Metabolic profiling to evaluate the impact of amantadine and rimantadine on the secondary metabolism of a model organism.
Topics: Adamantane; Amantadine; Metabolic Clearance Rate; Rimantadine; Secondary Metabolism | 2023 |
New Adamantane-Containing Edaravone Conjugates as Potential Neuroprotective Agents for ALS Treatments.
Topics: Adamantane; Amantadine; Amyotrophic Lateral Sclerosis; Edaravone; Humans; Neuroprotective Agents; Riluzole | 2023 |